MENLO PARK, Calif., May 06, 2023 (GLOBE NEWSWIRE) — Sight Sciences, Inc. SGHT, an eyecare technology company focused on developing and commercializing innovative technology that enables procedures intended to improve patients’ lives, today announced the results from a 12-month retrospective sub-analysis of IOP-lowering medication use following the three most commonly…Read More
Sight Sciences Announces 12month Results from the First Minimally Invasive Glaucoma Surgery MIGS Comparative Analysis of RealWorld Data RWD from the American Academy of Ophthalmology IRIS Registry Sight Sciences NASDAQSGHT
